aTyr Pharma | LIFE - Nettoeinkommen

Aktienkurs
0.81
Täglich Wechseln
-0.02 -2.37%
Monatlich
-20.00%
Jährlich
-78.04%
Q1 Prognose
0.78




Nettoeinkommen Veränderung Datum
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Ardelyx USD -407K 562K 2025-12
aTyr Pharma USD 24.56M 50.3M 2025-12
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD 56.84M 63.82M 2025-12
CSL USD 401M 96.5M 2025-12
Curis USD -11.8M 80K 2024-06
Galapagos EUR 782.15M 984.26M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Xoma USD -17.24M 33.23M 2024-09